ArticleActas espanolas de psiquiatria2025
Modified Morita Therapy for Treating Hospitalized Patients with Depression.
Article in Actas espanolas de psiquiatria, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prioritizing psychological relief: fast-absorbing collagen sutures improve parental well-being in pediatric facial trauma care.Frontiers in pediatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDepression is a common mental illness worldwide. Morita therapy is a novel and effective intervention method for treating depression patients. This study aimed to investigate the effects of modified Morita therapy on social functioning and quality of life in individuals suffering from depression.
methodsThe data of depressive patients hospitalized in Kangci Hospital of Jiaxing from June 2021 to May 2022 were collected and analyzed by propensity score matching (PSM). The control group received antidepressant treatment and standard psychiatric care (n = 30), while the study group received modified Morita therapy on the basis of standard treatment (n = 30). Both experimental groups received a six-week intervention. The 17-item Hamilton Depression Scale (HAMD-17) was used to assess the severity of depression before and after the intervention. Hamilton Anxiety Scale (HAMA) was used to assess the anxiety level of patients. Social Dysfunction Screening Scale (SDSS) was used to evaluate the social functioning of the patients. Generic Quality of Life Inventory-74 (GQOLI-74) was implemented to evaluate the quality of life of patients based on four dimensions: physical function, psychological function, social function, and material life status through 74 items.
resultsAfter six weeks of intervention, the study group exhibited significantly reduced HAMD-17, HAMA, and SDSS scores compared to the control group (p < 0.05). Furthermore, significant improvements were observed in physical function, psychological function, social function, material well-being domains, and the overall GQOLI-74 questionnaire scores within the study group compared to the control group (p < 0.05).
conclusionModified Morita therapy effectively alleviates depression and anxiety levels among depressed patients while enhancing their social functioning and improving their quality of life, thus highlighting its clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.